A Multi-centre Chart Review study of stage I-III Non-Small Cell Lung Cancer in China

Trial Identifier:	D133FR00236
Sponsor:	AstraZeneca
Start Date:	April 2026
Primary Completion Date:	April 2029
Study Completion Date:	April 2029
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Beijing, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.